ABIOMED, Inc. (ABMD) financial statements (2022 and earlier)

Company profile

Business Address 22 CHERRY HILL DR
DANVERS, MA 01923
State of Incorp. DE
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments144233192121362230212
Cash and cash equivalents144233192121433948
Short-term investments    319191164
Receivables89978591705443
Inventory, net of allowances, customer advances and progress billings90819081503527
Inventory90819081503527
Other undisclosed current assets5623772693841287
Total current assets:885788636677494327288
Noncurrent Assets
Operating lease, right-of-use asset96 
Property, plant and equipment1971971651451178823
Long-term investments and receivables    38471
Long-term investments    38471
Intangible assets, net (including goodwill)1601914748534648
Goodwill77793233363133
Intangible assets, net (excluding goodwill)831121515171415
Deferred income tax assets411 
Other noncurrent assets127113118851484
Deferred tax assets, net78713559
Other undisclosed noncurrent assets21118825122   
Total noncurrent assets:708706581377292223136
TOTAL ASSETS:1,5931,4941,2161,054786550424
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9910110890705838
Accounts payable3235333224219
Accrued liabilities67667557463828
Deferred revenue252419
Debt     1 
Deferred revenue and credits15109
Contract with customer, liability16
Other liabilities345    
Total current liabilities:127129132106857047
Noncurrent Liabilities
Long-term debt and lease obligation     16 
Capital lease obligations  16 
Liabilities, other than long-term debt3336181112139
Deferred tax liabilities, net1111
Deferred income tax liabilities11 
Other liabilities111091130
Business combination, contingent consideration, liability22259101098
Other undisclosed noncurrent liabilities  1    
Total noncurrent liabilities:3336191112299
Total liabilities:160165151117979855
Stockholders' equity
Stockholders' equity attributable to parent1,4331,3301,065937690452369
Common stock0000000
Treasury stock, value(304)(288)(265)(139)(67)(47)(27)
Additional paid in capital853801739691620566509
Accumulated other comprehensive loss(20)(11)(11)(15)(4)(21)(15)
Retained earnings (accumulated deficit)904828602399140(47)(99)
Total stockholders' equity:1,4331,3301,065937690452369
TOTAL LIABILITIES AND EQUITY:1,5931,4941,2161,054786550424

Income statement (P&L) ($ in millions)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
Revenues975848841769594445330
Revenue, net 445330
Cost of revenue(296)(162)(151)(130)(99)(71)(50)
Cost of goods and services sold(187)(162)(151)(130)(4)(71)(50)
Gross profit:679686690640495375279
Operating expenses(565)(456)(440)(415)(338)  
Other undisclosed operating loss     (285)(214)
Operating income:1142302492251579065
Nonoperating income7259839311
Investment income, nonoperating17128420
Other nonoperating income (expense)7252(5)30(0)(0)0
Other undisclosed loss from continuing operations before equity method investments, income taxes     (0) 
Income from continuing operations before equity method investments, income taxes:1872882572631609166
Other undisclosed income from continuing operations before income taxes     0 
Income from continuing operations before income taxes:1872882572631609166
Income tax expense(56)(63)(54)(4)(48)(39)(28)
Net income available to common stockholders, diluted:1302262032591125238

Comprehensive Income ($ in millions)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
Net income:1302262032591125238
Other comprehensive income (loss)(7)(0)4(10)16(6)3
Comprehensive income, net of tax, attributable to parent:1242252072491294641

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: